leadf
logo-loader
viewBiomedican

Biomedican Inc's organic, non-GMO CBD compound set for large-scale production in 2021

Biomedican Inc Chief Investment Officer Dennis O'Neill tells Proactive the Fremont, California-based CBD-focused group is focusing on commercializing its organic, non-GMO CBD compound.

O'Neill says because its CBD product produces 0.0% THC, it opens up distribution channels for the group. The group is expected to begin large-scale production in 2021.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Bam Bam Resources takes major step forward by increasing the size of Majuba...

Bam Bam Resources (CSE: BBR- OTC: NPEZF) CEO David Greenway shares news with Steve Darling from Proactive that the company has been able to increase its position on the Majuba Hill Project by 75%.   Greenway telling Proactive, the company added 168 new, unpatented lode mining claims...

3 hours, 29 minutes ago

2 min read